What insurance policy changes affect CPT 43270?

There are 6 tracked policy changes affecting CPT 43270, including updates from Anthem BCBS, Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for CPT 43270?

Payers that have issued tracked updates for CPT 43270 include: Anthem BCBS, Aetna.

How do I get notified when CPT 43270 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to CPT 43270. You will receive a daily digest email whenever a new policy change references this code.

Why do payers change policies for CPT 43270?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

43270 — A doctor uses an endoscope to find and destroy an abnormal growth or tissue problem in your esophagus or stomach.: Insurance Policy Changes

43270 Insurance Policy Changes

CPT 43270, in plain terms, covers A doctor uses an endoscope to find and destroy an abnormal growth or tissue problem in your esophagus or stomach. CPT 43270 is referenced in 6 tracked payer policy changes from Anthem BCBS and Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 43270 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

High impact

Radiofrequency Tumor Ablation (CPB 0492, reviewed 2026-07-29)

Aetna·Effective Jul 29, 2026

Aetna updated its Radiofrequency Tumor Ablation policy (CPB 0492) effective 2026-07-29, clarifying covered and non-covered indications. The policy maintains coverage for specific oncologic and benign conditions (e.g., HCC ≤5cm, renal cell carcinoma, thyroid nodules) but explicitly lists numerous experimental/investigational procedures and indications that are NOT covered, including RFA for biliary obstructions, pancreatic tumors, and curative treatment in surgical candidates. Billing teams must verify medical necessity against the specific approved indications and ensure claims include appropriate supporting documentation.

43270 Insurance Policy Changes

[New York] Precertification/prior authorization requirement updates — Carelon Medical Benefits Management

[Ohio] Precertification/prior authorization requirement updates — Carelon Medical Benefits Management

[Georgia] Precertification/prior authorization requirement updates — Carelon Medical Benefits Management

Cryoablation (CPB 0100, reviewed 2026-08-04)

Radiofrequency Tumor Ablation (CPB 0492, reviewed 2026-07-29)

Barrett's Esophagus (CPB 0728, reviewed 2025-11-25)